​

Danaher (DHR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DHR Stock Forecast

Danaher (DHR) stock forecast, based on 42 Wall Street analysts, predicts a 12-month average price target of $253.75, with a high of $270.00 and a low of $220.00. This represents a 30.09% increase from the last price of $195.06.

$195 $212 $229 $246 $263 $280 High: $270 Avg: $253.75 Low: $220 Last Closed Price: $195.06

DHR Stock Rating

Danaher stock's rating consensus is Buy, based on 42 Wall Street analysts. The breakdown includes 1 Strong Buy (2.38%), 30 Buy (71.43%), 10 Hold (23.81%), 1 Sell (2.38%), and 0 Strong Sell (0.00%).

Buy
Total 42 1 10 30 1 Strong Sell Sell Hold Buy Strong Buy

DHR Price Target Upside V Benchmarks

TypeNameUpside
StockDanaher30.09%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks30.02%

Price Target Trends

1M3M12M
# Anlaysts-617
Avg Price Target-$254.17$249.65
Last Closing Price$195.06$195.06$195.06
Upside/Downside-30.30%27.99%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 264183--25
Feb, 264183--25
Jan, 264183--25
Dec, 253173--23
Nov, 253173--23
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 29, 2026Robert W. Baird$251.00$224.5411.78%28.68%
Jan 28, 2026Jefferies$265.00$224.5418.02%35.86%
Jan 28, 2026Vijay KumarEvercore ISI$254.00$224.4813.15%30.22%
Jan 14, 2026Argus Research$265.00$235.5612.50%35.86%
Jan 05, 2026Vijay KumarEvercore ISI$250.00$231.727.89%28.17%
Dec 15, 2025Wells Fargo$240.00$226.715.86%23.04%
Dec 09, 2025Goldman Sachs$265.00$224.4818.05%35.86%
Dec 01, 2025Morgan Stanley$270.00$224.1420.46%38.42%
Oct 23, 2025Wells Fargo$230.00$218.105.46%17.91%
Oct 22, 2025Robert W. Baird$247.00$220.7711.88%26.63%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 29, 2026Deutsche BankBuyBuyhold
Jan 29, 2026KeyBancOverweightOverweighthold
Jan 28, 2026JefferiesBuyBuyhold
Jan 28, 2026Evercore ISIOutperformOutperformhold
Jan 07, 2026Cowen & Co.BuyBuyhold
Jan 05, 2026Evercore ISIOutperformOutperformhold
Jan 05, 2026GuggenheimBuyBuyhold
Dec 18, 2025KeyBancOverweightOverweighthold
Dec 09, 2025Goldman SachsNeutralBuyinitialise
Dec 01, 2025Morgan StanleyUnderweightOverweightinitialise

Financial Forecast

EPS Forecast

$5 $6 $7 $8 $9 $10 $11 $12 $13 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$8.77$9.80$6.44$5.33$5.07----
Avg Forecast$8.77$9.41$7.43$7.50$7.99$8.94$10.05$11.00$11.54
High Forecast$8.95$9.80$7.48$7.54$8.38$9.92$10.38$11.47$12.04
Low Forecast$8.62$9.13$7.38$7.46$7.81$8.32$9.71$10.74$11.27
Surprise %-4.14%-13.32%-28.93%-36.55%----

Revenue Forecast

$24B $25B $27B $29B $31B $33B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$29.45B$26.64B$23.89B$23.88B$24.57B----
Avg Forecast$29.25B$30.97B$27.12B$23.79B$24.41B$26.21B$27.99B$29.69B$31.82B
High Forecast$29.71B$31.96B$27.40B$23.86B$24.94B$27.91B$28.01B$30.67B$32.87B
Low Forecast$28.85B$30.26B$26.97B$23.73B$23.87B$25.49B$27.97B$29.15B$31.24B
Surprise %0.69%-13.96%-11.90%0.37%0.66%----

Net Income Forecast

$3B $4B $5B $7B $8B $9B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$6.43B$7.21B$4.76B$3.90B$3.61B----
Avg Forecast$6.52B$3.80B$4.20B$5.53B$5.97B$6.72B$7.41B$8.11B$8.51B
High Forecast$6.65B$4.56B$5.04B$5.56B$6.18B$7.31B$7.65B$8.46B$8.87B
Low Forecast$6.40B$3.04B$3.36B$5.50B$5.76B$6.13B$7.16B$7.92B$8.30B
Surprise %-1.31%89.61%13.43%-29.53%-39.46%----

DHR Forecast FAQ

Is Danaher stock a buy?

Danaher stock has a consensus rating of Buy, based on 42 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 30 Buy, 10 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Danaher is a favorable investment for most analysts.

What is Danaher's price target?

Danaher's price target, set by 42 Wall Street analysts, averages $253.75 over the next 12 months. The price target range spans from $220 at the low end to $270 at the high end, suggesting a potential 30.09% change from the previous closing price of $195.06.

How does Danaher stock forecast compare to its benchmarks?

Danaher's stock forecast shows a 30.09% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (30.02%).

What is the breakdown of analyst ratings for Danaher over the past three months?

  • March 2026: 16.00% Strong Buy, 72.00% Buy, 12.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 16.00% Strong Buy, 72.00% Buy, 12.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 16.00% Strong Buy, 72.00% Buy, 12.00% Hold, 0% Sell, 0% Strong Sell.

What is Danaher’s EPS forecast?

Danaher's average annual EPS forecast for its fiscal year ending in December 2026 is $8.94, marking a 76.33% increase from the reported $5.07 in 2025. Estimates for the following years are $10.05 in 2027, $11 in 2028, and $11.54 in 2029.

What is Danaher’s revenue forecast?

Danaher's average annual revenue forecast for its fiscal year ending in December 2026 is $26.21B, reflecting a 6.68% increase from the reported $24.57B in 2025. The forecast for 2027 is $27.99B, followed by $29.69B for 2028, and $31.82B for 2029.

What is Danaher’s net income forecast?

Danaher's net income forecast for the fiscal year ending in December 2026 stands at $6.72B, representing an 86.04% increase from the reported $3.61B in 2025. Projections indicate $7.41B in 2027, $8.11B in 2028, and $8.51B in 2029.